Antibióticos
Os antibióticos são compostos projetados para destruir ou inibir o crescimento de vários microrganismos, desempenhando um papel crucial no tratamento de infecções e na prevenção da disseminação de doenças. Esta categoria oferece uma ampla variedade de ingredientes ativos especificamente para pesquisa no campo bioquímico. Esses compostos são ferramentas essenciais no estudo dos mecanismos bacterianos, padrões de resistência e no desenvolvimento de novos agentes terapêuticos. Os pesquisadores podem explorar uma grande variedade de antibióticos para entender seus efeitos, otimizar seu uso e desenvolver novos tratamentos para combater ameaças microbianas emergentes. A disponibilidade de um espectro tão amplo de antibióticos apoia a pesquisa avançada e a inovação em microbiologia e ciências farmacêuticas.
Subcategorias de "Antibióticos"
- Antibióticos macrolídeos(26 produtos)
- Antibióticos Esteróides(31 produtos)
- Antibióticos de tetraciclina(20 produtos)
- Antibióticos β-Lactâmicos(11 produtos)
Foram encontrados 4100 produtos de "Antibióticos"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Oligomycin A
CAS:<p>Oligomycin A is a macrolide antibiotic, which is isolated from the Streptomyces species of bacteria. Its mode of action involves inhibiting ATP synthase by binding to the F_O subunit of the enzyme complex in the mitochondrial membrane. This binding effectively stops the flow of protons across the membrane, which is critical for ATP generation through oxidative phosphorylation.</p>Fórmula:C45H74O11Pureza:Min. 95%Cor e Forma:PowderPeso molecular:791.06 g/mol8-Fluoro erythromycin
CAS:<p>8-Fluoro erythromycin is a synthetic derivative of the macrolide antibiotic erythromycin. It is derived from the fermentation of *Streptomyces erythraeus*, a species known for producing erythromycin, which is chemically modified to include a fluorine atom at the eighth position. This modification enhances its pharmacokinetic properties, improving its stability and bioavailability compared to the parent compound.</p>Fórmula:C37H66FNO13Pureza:Min. 95%Peso molecular:751.92 g/molCeftaroline fosamil acetate
CAS:<p>Cephalosporin antibiotic active against gram-positive bacteria including MRSA</p>Fórmula:C24H25N8O10PS4Pureza:Min. 98 Area-%Peso molecular:744.74 g/molRifamdin
CAS:<p>Rifamdin is an antibiotic, which is a chemical substance derived from the source compound rifampicin. Its mode of action involves the inhibition of bacterial DNA-dependent RNA polymerase, which effectively suppresses bacterial RNA synthesis, leading to cell death. This mechanism primarily targets Mycobacterium tuberculosis, the causative agent of tuberculosis.</p>Fórmula:C46H64N4O12Pureza:Min. 95%Peso molecular:865.02 g/molLydicamycin
CAS:<p>Lydicamycin is an antibacterial compound, which is a polyketide-derived antibiotic produced by the microorganism Streptomyces. This natural compound functions by inhibiting bacterial protein synthesis, effectively interrupting critical cellular processes within susceptible bacteria. The mode of action primarily focuses on binding to the bacterial ribosome, thereby disrupting protein production and inhibiting bacterial growth.</p>Fórmula:C47H74N4O10Pureza:Min. 95%Peso molecular:855.11 g/molN'-Desmethyl azithromycin
CAS:<p>N'-Desmethyl azithromycin is a semi-synthetic derivative antibiotic, which is derived from the chemical modification of azithromycin, a macrolide antibiotic sourced originally from the bacterium *Streptomyces erythreus*. It functions primarily by inhibiting bacterial protein synthesis, binding specifically to the 50S ribosomal subunit, which results in the prevention of transpeptidation and translocation processes during translation. This action effectively halts bacterial growth, rendering it bacteriostatic.</p>Fórmula:C37H70N2O12Pureza:Min. 95%Peso molecular:734.96 g/molClindamycin B hydrochloride
CAS:<p>Clindamycin B hydrochloride is a semi-synthetic antibiotic, which is derived from the parent compound, lincomycin, obtained from the bacterium *Streptomyces lincolnensis*. It exerts its antibacterial effects by binding to the 50S subunit of the bacterial ribosome, inhibiting protein synthesis by preventing peptide bond formation, which is essential for bacterial growth and survival.</p>Fórmula:C17H31ClN2O5S•HClPureza:Min. 95%Cor e Forma:White To Off-White SolidPeso molecular:447.42 g/molFosmidomycin sodium
CAS:<p>Fosmidomycin sodium is an antibiotic compound, which is derived from phosphonic acid. It functions as an inhibitor of the enzyme 1-deoxy-D-xylulose 5-phosphate reductoisomerase (DXR), crucial in the non-mevalonate pathway of isoprenoid biosynthesis. By targeting this enzyme, fosmidomycin sodium disrupts the production of isoprenoids, essential components for the growth and survival of certain bacteria and parasites.</p>Fórmula:C4H9NNaO5PPureza:Min. 95%Peso molecular:205.08 g/molErythromycin B
CAS:<p>Erythromycin B is a semisynthetic macrolide antibiotic, which is derived from the actinomycete *Saccharopolyspora erythraea*. Its mode of action involves inhibiting bacterial protein synthesis by binding to the 50S ribosomal subunit. This interference with protein synthesis effectively hampers bacterial growth, making it a potent bacteriostatic agent.</p>Fórmula:C37H67NO12Pureza:90%NmrPeso molecular:717.93 g/mol6'-N-Cbz-kanamycin A
CAS:<p>6'-N-Cbz-kanamycin A is a semi-synthetic aminoglycoside antibiotic derivative, specifically a Cbz (carbobenzyloxy) protected form of kanamycin A. It is derived from the natural product kanamycin, which is an antibiotic obtained from the bacterium *Streptomyces kanamyceticus*. The modification involves the introduction of a protective Cbz group at the 6' position, which can improve solubility, stability, or enable further chemical modifications.</p>Fórmula:C26H42N4O13Pureza:Min. 95%Peso molecular:618.63 g/molRolitetracycline
CAS:<p>Rolitetracycline is a semi-synthetic tetracycline antibiotic, which is derived from the natural compound tetracycline. It functions primarily by inhibiting protein synthesis in susceptible bacteria. This is achieved through the binding to the 30S ribosomal subunit, effectively blocking the attachment of aminoacyl-tRNA to the mRNA-ribosome complex, thereby preventing the addition of new amino acids to the nascent peptide chain. As a result, bacterial cell growth is inhibited, leading to bacteriostatic effects.</p>Fórmula:C27H33N3O8Pureza:Min. 95%Cor e Forma:PowderPeso molecular:527.57 g/molClindamycin-2,4-diphosphate
CAS:<p>Clindamycin-2,4-diphosphate is a phosphorylated derivative of the antibiotic clindamycin, which is a semi-synthetic lincosamide antibiotic originally derived from Streptomyces lincolnensis. Its mode of action involves the inhibition of bacterial protein synthesis by binding to the 50S ribosomal subunit, thereby preventing peptide chain elongation during translation. This mechanism effectively disrupts protein production in susceptible bacteria, leading to their growth inhibition or death.</p>Fórmula:C18H35ClN2O11P2SPureza:Min. 95%Peso molecular:584.94 g/molAnhydro erythromycin A
CAS:<p>Anhydro erythromycin A is a semi-synthetic derivative of erythromycin A, which has been shown to be an effective inhibitor of bacterial growth, showing higher selectivity for this inhibition. It is a prodrug that is activated by acid catalysis and can be used as a substitute against methicillin-resistant staphylococcus. Anhydro erythromycin A was developed with the goal of increasing its stability and its potency against methicillin-resistant Staphylococcus aureus, which has been shown to be resistant to erythromycin.</p>Fórmula:C37H65NO12Pureza:Min. 95%Cor e Forma:White PowderPeso molecular:715.91 g/mol2'-O-Acetylspiramycin I
CAS:<p>2'-O-Acetylspiramycin I is a semi-synthetic derivative of spiramycin, which is a macrolide antibiotic originally sourced from the bacterium *Streptomyces ambofaciens*. The modification involves the acetylation at the 2'-hydroxyl group of spiramycin, enhancing certain pharmacokinetic properties.</p>Fórmula:C45H76N2O15Pureza:Min. 95%Peso molecular:885.09 g/molVirginiamycin - Complex of M1+S1
CAS:<p>Virginiamycin - Complex of M1+S1 is an antibiotic compound, which is derived from the actinobacterium Streptomyces virginiae. It functions through the inhibition of bacterial protein synthesis by binding to the 50S ribosomal subunit, thereby obstructing peptide bond formation and impeding microbial growth. The complex is composed of two major components: Virginiamycin M1 and Virginiamycin S1, which synergistically enhance antimicrobial efficacy.</p>Fórmula:C71H84N10O17Pureza:Min. 95%Peso molecular:1,349.48 g/molCefotiam
CAS:<p>Cefotiam is a broad-spectrum cephalosporin antibiotic, which is a beta-lactam compound derived from the mold Acremonium. It functions by inhibiting bacterial cell wall synthesis, particularly by targeting penicillin-binding proteins, which leads to cell lysis and death in susceptible bacteria. This mechanism of action makes it effective against various Gram-positive and Gram-negative bacteria.</p>Fórmula:C18H23N9O4S3Pureza:Min. 95%Cor e Forma:PowderPeso molecular:525.62 g/molPhleomycin
CAS:<p>Phleomycin is an antibiotic, which is derived from the bacterium *Streptomyces verticillus*. Its mode of action involves binding to DNA and inducing breaks by generating free radicals in the presence of oxygen and ferrous ions, leading to cell death. Phleomycin is prominently used in molecular biology applications as a selective agent in the generation of stable transfectants. It is particularly effective in selecting for cells that have integrated vectors conferring resistance, such as the Sh ble gene used in yeast, plant, and mammalian cell systems. Due to its potent DNA-cleaving ability, Phleomycin is valuable in studies requiring stringent selection pressure. Researchers commonly utilize it in experiments focusing on genetic modification and cellular resistance development.</p>Fórmula:C51H75N17O21S2Pureza:Min. 95%Peso molecular:1,326.38 g/molPiericidin A
CAS:<p>Piericidin A is a microbial metabolite, specifically a type of polyketide, which is derived from the bacterium of the genus Streptomyces. This compound acts as an electron transport chain inhibitor by specifically binding to the ubiquinone binding site of complex I (NADH:ubiquinone oxidoreductase) in mitochondria. This mode of action results in the disruption of ATP production through oxidative phosphorylation.</p>Fórmula:C25H37NO4Pureza:Min. 95%Peso molecular:415.57 g/molArbekacin sulfate
CAS:<p>Inhibitor of DNA replication; aminoglycoside class</p>Fórmula:C22H44N6O10·xH2SO4Pureza:Min. 95%Cor e Forma:White PowderPeso molecular:650.7 g/mol
